Financials · CV
For the twelve months ended Jun 30, 2026, CapsoVision Inc. reported $13.89M of revenue and -$29.83M of net income.
CV revenue was $3.64M in fiscal Q2 2026 (ended Jun 30, 2026), up 9.9% from a year earlier and up 30.5% from the prior quarter. For the full fiscal 2025 it was $13.55M, up 15.3% from fiscal 2024.
CV net income was -$7.48M in fiscal Q2 2026 (ended Jun 30, 2026), compared with -$4.63M a year earlier. For the full fiscal 2025 it was -$25.32M, compared with -$19.90M in fiscal 2024.
CV diluted EPS was -$0.15 in fiscal Q2 2026 (ended Jun 30, 2026). For the full fiscal 2025 it was -$1.03.
CV free cash flow was -$8.40M in fiscal Q2 2026 (ended Jun 30, 2026), compared with -$4.56M a year earlier. For the full fiscal 2025 it was -$22.95M, compared with -$20.24M in fiscal 2024.
| Line item | Dec 31, 2025 | Dec 31, 2024 |
|---|---|---|
| Revenue | $13.55M | $11.76M |
| Cost of revenue | $6.38M | $5.38M |
| Gross profit | $7.17M | $6.38M |
| Research and development | $18.31M | $15.12M |
| Selling, general and admin | $6.85M | $4.21M |
| Operating income | -$25.52M | -$19.92M |
| Pre-tax income | -$25.29M | -$19.89M |
| Income tax | $24.0K | $11.0K |
| Net income | -$25.32M | -$19.90M |
| EPS, basic | -$1.03 | -$9.85 |
| EPS, diluted | -$1.03 | -$9.85 |
| Diluted shares | 24.6M | 2.0M |
| Line item | Dec 31, 2025 | Dec 31, 2024 |
|---|---|---|
| Receivables | $2.50M | $2.00M |
| Inventory | $2.99M | $2.63M |
| Current assets | $16.67M | $14.85M |
| Total assets | $18.16M | $16.80M |
| Current liabilities | $4.43M | $1.80M |
| Total liabilities | $4.90M | $2.69M |
| Shareholders' equity | $13.26M | -$129.51M |
| Line item | Dec 31, 2025 | Dec 31, 2024 |
|---|---|---|
| Operating cash flow | -$22.86M | -$20.09M |
| Capital expenditures | $90.0K | $153.0K |
| Free cash flow | -$22.95M | -$20.24M |
| Investing cash flow | -$90.0K | -$153.0K |
| Financing cash flow | $23.60M | $15.07M |
| Stock-based compensation | $826.0K | $156.0K |
| Depreciation and amortization | $216.0K | $206.0K |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.64M | $2.79M | $3.92M | $3.54M | $3.31M | $2.78M | $3.45M | $2.97M | $2.84M | $2.50M |
| Cost of revenue | $1.77M | $1.46M | $1.96M | $1.62M | $1.50M | $1.29M | $1.72M | $1.31M | $1.25M | $1.10M |
| Gross profit | $1.87M | $1.33M | $1.95M | $1.91M | $1.81M | $1.49M | $1.73M | $1.66M | $1.59M | $1.39M |
| Research and development | $5.31M | $4.43M | $5.72M | $6.09M | $3.39M | $3.11M | $3.12M | $4.52M | $4.22M | $3.26M |
| Selling, general and admin | $2.21M | $1.90M | $1.75M | $2.07M | $1.22M | $1.81M | $1.45M | $1.19M | $857.0K | $704.0K |
| Operating income | -$7.58M | -$7.09M | -$7.46M | -$8.02M | -$4.65M | -$5.38M | -$4.63M | -$5.80M | -$5.27M | -$4.21M |
| Pre-tax income | -$7.48M | -$7.03M | -$7.37M | -$7.92M | -$4.63M | -$5.38M | -$4.63M | -$5.79M | -$5.27M | -$4.20M |
| Income tax | $0 | $0 | $24.0K | $0 | $0 | $0 | $11.0K | $0 | $0 | $0 |
| Net income | -$7.48M | -$7.03M | -$7.39M | -$7.92M | -$4.63M | -$5.38M | -$4.64M | -$5.79M | -$5.27M | -$4.20M |
| EPS, basic | -$0.15 | -$0.15 | - | -$0.17 | -$2.02 | -$2.49 | - | -$2.79 | -$2.58 | - |
| EPS, diluted | -$0.15 | -$0.15 | - | -$0.17 | -$2.02 | -$2.49 | - | -$2.79 | -$2.58 | - |
| Diluted shares | 49.9M | 47.5M | - | 46.2M | 2.3M | 2.2M | - | 2.1M | 2.0M | - |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Receivables | $2.27M | $1.93M | $2.50M | $1.87M | $1.85M | - | $2.00M | - | - | - |
| Inventory | $4.70M | $3.49M | $2.99M | $3.19M | $3.04M | - | $2.63M | - | - | - |
| Current assets | $17.28M | $24.50M | $16.67M | $24.05M | $7.80M | - | $14.85M | - | - | - |
| Total assets | $18.57M | $25.95M | $18.16M | $25.66M | $9.55M | - | $16.80M | - | - | - |
| Current liabilities | $5.16M | $5.36M | $4.43M | $4.63M | $4.22M | - | $1.80M | - | - | - |
| Total liabilities | $5.40M | $5.72M | $4.90M | $5.22M | $4.91M | - | $2.69M | - | - | - |
| Shareholders' equity | $13.17M | $20.22M | $13.26M | $20.44M | -$138.99M | -$134.70M | -$129.51M | -$124.99M | -$119.21M | -$113.99M |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$8.40M | -$6.07M | -$7.69M | -$5.67M | -$4.53M | -$4.99M | -$5.40M | -$7.06M | - | - |
| Capital expenditures | $0 | $48.0K | $8.0K | $12.0K | $30.0K | $40.0K | $0 | $4.0K | - | - |
| Free cash flow | -$8.40M | -$6.11M | -$7.69M | -$5.68M | -$4.56M | -$5.03M | -$5.40M | -$7.06M | - | - |
| Investing cash flow | $0 | -$48.0K | -$8.0K | -$12.0K | -$30.0K | -$40.0K | $0 | -$4.0K | - | - |
| Financing cash flow | -$443.0K | $13.95M | $15.0K | $22.39M | $1.17M | $34.0K | $5.00M | $10.00M | - | - |
| Stock-based compensation | $577.0K | $334.0K | $197.0K | $307.0K | $170.0K | $152.0K | $113.0K | $15.0K | - | - |
| Depreciation and amortization | $58.0K | $56.0K | $55.0K | $54.0K | $55.0K | $52.0K | $51.0K | $52.0K | $52.0K | $51.0K |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 9.9% | 0.3% | 13.5% | 19.3% | 16.6% | 11.5% | - | - | - | - |
| Gross margin | 51.4% | 47.6% | 49.9% | 54.1% | 54.6% | 53.7% | 50.2% | 55.9% | 56.0% | 55.9% |
| Operating margin | -208.1% | -254.0% | -190.5% | -226.7% | -140.3% | -193.4% | -134.2% | -195.7% | -185.4% | -168.7% |
| Net margin | -205.4% | -251.9% | -188.7% | -223.9% | -139.5% | -193.1% | -134.4% | -195.3% | -185.2% | -168.3% |
| Free cash flow margin | -230.7% | -219.0% | -196.4% | -160.5% | -137.4% | -180.6% | -156.4% | -238.0% | - | - |
| Current ratio | 3.35 | 4.57 | 3.77 | 5.19 | 1.85 | - | 8.24 | - | - | - |
Source: XBRL data CapsoVision Inc. files with the SEC, latest filing dated Aug 13, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| CV | $13.89M | +11.0% | -$29.83M | -214.7% | $335.9M |
| MDT | $37.54B | +9.8% | $5.24B | 14.0% | $130.22B |
| LIVN | $1.51B | +11.7% | $196.06M | 13.0% | $4.96B |
| ITGR | $1.83B | -0.3% | $103.70M | 5.7% | $4.30B |
| TMDX | $727.65M | +28.5% | $144.45M | 19.9% | $3.06B |
| AXGN | $266.93M | +24.3% | -$31.92M | -12.0% | $2.99B |
| CNMD | $1.37B | +1.6% | $73.43M | 5.4% | $1.53B |
| CBLL | $108.72M | +31.3% | -$73.88M | -68.0% | $1.03B |
| INMD | $370.50M | -6.2% | $93.83M | 25.3% | $765.9M |